Last reviewed · How we verify
GW685698X containing magnesium stearate — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
GW685698X containing magnesium stearate (GW685698X containing magnesium stearate) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| GW685698X containing magnesium stearate TARGET | GW685698X containing magnesium stearate | GlaxoSmithKline | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- GW685698X containing magnesium stearate CI watch — RSS
- GW685698X containing magnesium stearate CI watch — Atom
- GW685698X containing magnesium stearate CI watch — JSON
- GW685698X containing magnesium stearate alone — RSS
Cite this brief
Drug Landscape (2026). GW685698X containing magnesium stearate — Competitive Intelligence Brief. https://druglandscape.com/ci/gw685698x-containing-magnesium-stearate. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab